SynOx Therapeutics

Biotech · Dublin, IE

Dublin/Oxford biopharma developing emactuzumab for tenosynovial giant cell tumour.

In the network

Shares the most investors with (number = shared investors):

Create a free EquityFlow account to see SynOx Therapeutics's 1 funding round, 3 investors, 12 similar companies.